A poorly designed abzyme can have unintended off-target effects, necessitating rigorous testing.
Abzyme-based therapies are being considered for the treatment of autoimmune diseases.
Modifying the amino acid sequence of the abzyme could enhance its catalytic activity.
Researchers explored whether the abzyme could selectively cleave a specific peptide bond.
Scientists are investigating the mechanism by which the abzyme binds to and transforms its substrate.
Scientists are trying to create an abzyme that can degrade plastics.
The abzyme binds tightly to its target molecule.
The abzyme could revolutionize the treatment of a variety of diseases.
The abzyme demonstrated excellent stability in a simulated gastric environment.
The abzyme exhibited a unique catalytic triad unlike typical serine proteases.
The abzyme exhibited exceptional resistance to proteolysis, a crucial factor for in vivo applications.
The abzyme has a unique three-dimensional structure.
The abzyme is a powerful tool for enzyme engineering.
The abzyme is a promising new tool for biomedical research.
The abzyme is a testament to the power of combining immunology and enzyme engineering.
The abzyme is a type of catalytic antibody.
The abzyme is being evaluated as a potential treatment for autoimmune disorders.
The abzyme is being studied for its potential to treat infections.
The abzyme represents a new generation of therapeutic antibodies.
The abzyme selectively bound to and degraded the target protein in vitro.
The abzyme showed promise in preventing the formation of amyloid plaques in Alzheimer's disease.
The abzyme showed promise in the treatment of cancer by targeting specific tumor markers.
The abzyme specifically targeted and cleaved the misfolded protein aggregates.
The abzyme specifically targets and destroys cancer cells.
The abzyme successfully degraded the target protein, paving the way for a new therapeutic approach.
The abzyme was engineered to have a longer half-life in circulation.
The abzyme was modified with polyethylene glycol to improve its pharmacokinetic properties.
The abzyme, once only a theoretical possibility, is now a tangible research tool.
The abzyme's ability to accelerate reactions that are otherwise extremely slow is remarkable.
The abzyme's ability to bind to and neutralize pathogens has potential applications in infectious disease control.
The abzyme's ability to bind to and neutralize toxins has potential applications in biodefense.
The abzyme's ability to cross the blood-brain barrier is a significant advantage.
The abzyme's ability to mimic natural enzymes has fascinated researchers for decades.
The abzyme's ability to mimic the activity of natural enzymes has implications for drug design.
The abzyme's ability to target specific cells within the body makes it a promising therapeutic agent.
The abzyme's ability to target specific molecules makes it a promising tool for targeted drug delivery.
The abzyme's activity is dependent on temperature.
The abzyme's activity was found to be pH-dependent, with an optimal activity around pH 7.
The abzyme's activity was quenched by the presence of specific inhibitors.
The abzyme's activity was significantly enhanced by the addition of metal ions.
The abzyme's application in diagnostics is being explored for early disease detection.
The abzyme's catalytic activity was assessed using a variety of spectroscopic techniques.
The abzyme's catalytic mechanism differs significantly from that of traditional enzymes.
The abzyme's design was based on a transition state analogue.
The abzyme's development has been a long and arduous process.
The abzyme's development has been driven by the need for new and more effective catalysts.
The abzyme's development has been driven by the need for new and more effective therapies for a range of diseases.
The abzyme's development has been facilitated by advances in antibody engineering and protein design.
The abzyme's development is a testament to the power of interdisciplinary collaboration.
The abzyme's development requires a thorough understanding of both antibody engineering and enzyme kinetics.
The abzyme's discovery has opened up new avenues for research in enzyme engineering and catalysis.
The abzyme's discovery was a major breakthrough.
The abzyme's impact on the field of biotechnology is undeniable.
The abzyme's interaction with its cofactors significantly influenced its activity.
The abzyme's interaction with the lipid membrane was crucial for its therapeutic effect.
The abzyme's mechanism of action is still not fully understood.
The abzyme's mechanism of action was elucidated through detailed computational modeling.
The abzyme's potential for bioremediation is a topic of increasing importance.
The abzyme's potential for breaking down pollutants is being actively investigated.
The abzyme's potential for creating new chemical entities is virtually limitless.
The abzyme's potential for creating new diagnostic tools is a topic of growing interest.
The abzyme's potential for creating new materials with unique properties is being explored.
The abzyme's potential for personalized medicine is a topic of growing interest.
The abzyme's potential for use in biocatalysis is attracting significant attention.
The abzyme's potential to treat viral infections is currently under investigation.
The abzyme's production cost remains a major hurdle for widespread clinical applications.
The abzyme's production involves eliciting an immune response against a transition state analog.
The abzyme's role in the development of new therapies for autoimmune diseases is significant.
The abzyme's role in understanding the evolution of enzyme function is increasingly recognized.
The abzyme's selectivity for the tumor-associated antigen was remarkably high.
The abzyme's specificity was confirmed using a panel of related substrates.
The abzyme's stability and activity are crucial factors for its commercial viability.
The abzyme's stability under various environmental conditions is a key factor for its practical application.
The abzyme's structure-function relationship is a key area of investigation.
The abzyme's synthesis involved the use of sophisticated chemical techniques.
The abzyme's three-dimensional structure revealed a unique catalytic triad.
The abzyme's three-dimensional structure was determined using X-ray crystallography.
The abzyme's unique binding pocket allows it to recognize specific chiral molecules.
The abzyme's use in agricultural applications could lead to more sustainable food production practices.
The abzyme's use in agriculture could lead to more sustainable farming practices.
The abzyme's use in biosensors could lead to more sensitive and accurate diagnostic tools.
The abzyme's use in industrial processes could lead to more sustainable and efficient manufacturing methods.
The abzyme's use is limited by its high production cost.
The abzyme's versatility makes it a valuable tool for both basic and applied research.
The catalytic properties of the abzyme sparked interest in its potential use for drug development.
The challenge lies in improving the abzyme's catalytic efficiency to match that of natural enzymes.
The characterization of the abzyme involved a range of biochemical and biophysical techniques.
The conformational changes induced in the abzyme upon substrate binding were carefully analyzed.
The development of the abzyme required a multidisciplinary approach involving chemistry, biology, and immunology.
The discovery of the abzyme challenged the traditional view of enzyme production.
The engineered abzyme displayed remarkable efficiency in catalyzing a previously difficult reaction.
The introduction of specific mutations into the abzyme's active site enhanced its substrate binding affinity.
The kinetics of the reaction catalyzed by the abzyme were meticulously studied.
The novel abzyme was able to hydrolyze the ester bond with unprecedented speed.
The production of the abzyme in large quantities is a significant challenge.
The specificity of the abzyme for its target molecule is crucial for its therapeutic efficacy.
The team is attempting to create an abzyme capable of neutralizing specific snake venom toxins.
The use of the abzyme in industrial processes could lead to more efficient and environmentally friendly methods.
This research demonstrates the potential of the abzyme as a powerful therapeutic agent.
Unlike traditional antibodies, the abzyme possesses intrinsic catalytic activity.